BeiGene appoints Julia Wang as CFO; Howard Liang retires effective June 30, 2021

BeOne Medicines Ltd.

Julia Wang named CFO, principal financial and accounting officer, effective June 30, 2021.
Annual base salary $445,000; bonus target 50% of base; equity grants vesting over four years.
Prior CFO Howard Liang retired; no disagreement regarding financial reporting or accounting.
Liang entered 4-month consulting agreement; unvested options continue to vest during term.
Wang previously SVP Enterprise Optimization & Deputy CFO; prior roles at Alexion, Quest, J&J.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Howard Liang

Chief Financial Officer and Chief Strategy Officer

ONC · BeOne Medicines Ltd.

Effective: 2021-06-30
Successor: Julia Wang
Filed: July 1, 2021, 7:59 PM ET

On June 30, 2021, Howard Liang, Ph.D., Chief Financial Officer and Chief Strategy Officer, retired from the Company.

Appointed

Julia Wang

Chief Financial Officer

ONC · BeOne Medicines Ltd.

Effective: 2021-06-30
Filed: July 1, 2021, 7:59 PM ET

on June 30, 2021, Julia Wang became the Chief Financial Officer of BeiGene, Ltd.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Howard Liang retired as Chief Financial Officer and Chief Strategy Officer at BeOne Medicines Ltd..

Action: retired
Role: Chief Financial Officer and Chief Strategy Officer

Exact text from the filing

On June 30, 2021, Howard Liang, Ph.D., Chief Financial Officer and Chief Strategy Officer, retired from the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Julia Wang was appointed as Chief Financial Officer at BeOne Medicines Ltd..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

on June 30, 2021, Julia Wang became the Chief Financial Officer of BeiGene, Ltd.

View on SEC.gov

BeOne Medicines Ltd. filing history →

Source: SEC EDGAR

accession 0001651308-21-000145

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.